{"id":"https://openalex.org/W1883154993","doi":"https://doi.org/10.1016/j.molonc.2015.10.018","title":"Tumor\u2010infiltrating lymphocytes for the treatment of metastatic cancer","display_name":"Tumor\u2010infiltrating lymphocytes for the treatment of metastatic cancer","alternate_titles":[],"publication_year":2015,"publication_date":"2015-10-30","ids":{"openalex":"https://openalex.org/W1883154993","doi":"https://doi.org/10.1016/j.molonc.2015.10.018","mag":"1883154993","pmid":"https://pubmed.ncbi.nlm.nih.gov/26578452","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/5528735"},"language":"en","primary_location":{"id":"doi:10.1016/j.molonc.2015.10.018","doi":"https://doi.org/10.1016/j.molonc.2015.10.018","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.molonc.2015.10.018","pdf_url":"https://febs.onlinelibrary.wiley.com/doi/pdfdirect/10.1016/j.molonc.2015.10.018","source":{"id":"https://openalex.org/S80282989","display_name":"Molecular Oncology","issn_l":"1574-7891","issn":["1574-7891","1878-0261"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","oarl","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Oncology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1883154993"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://febs.onlinelibrary.wiley.com/doi/pdfdirect/10.1016/j.molonc.2015.10.018","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5114036957","display_name":"Marnix H. Geukes Foppen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2898336195","display_name":"The Netherlands Cancer Institute","ror":"https://ror.org/03xqtf034","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2898336195"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"M.H. Geukes Foppen","raw_affiliation_strings":["Department of Medical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. Electronic address: m.geukes@nki.nl","Department of Medical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. Electronic address: m.geukes@nki.nl","institution_ids":["https://openalex.org/I2898336195"]},{"raw_affiliation_string":"Department of Medical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands","institution_ids":["https://openalex.org/I2898336195"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025825017","display_name":"Marco Donia","orcid":"https://orcid.org/0000-0003-4966-9752","observed_orcids":["https://orcid.org/0000-0003-4966-9752"]},"institutions":[{"id":"https://openalex.org/I124055696","display_name":"University of Copenhagen","ror":"https://ror.org/035b05819","country_code":"DK","type":"education","lineage":["https://openalex.org/I124055696"]},{"id":"https://openalex.org/I2801827564","display_name":"Herlev Hospital","ror":"https://ror.org/00wys9y90","country_code":"DK","type":"healthcare","lineage":["https://openalex.org/I2801827564","https://openalex.org/I2802567020"]}],"countries":["DK"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"M. Donia","raw_affiliation_strings":["Center for Cancer Immune Therapy, Department of Haematology and Oncology, Herlev Hospital, University of Copenhagen, Herlev Ringvej 75, 2730 Herlev, Denmark. Electronic address: Marco.Donia@regionh.dk","Center for Cancer Immune Therapy, Department of Haematology and Oncology, Herlev Hospital, University of Copenhagen, Herlev Ringvej 75, 2730 Herlev, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Cancer Immune Therapy, Department of Haematology and Oncology, Herlev Hospital, University of Copenhagen, Herlev Ringvej 75, 2730 Herlev, Denmark. Electronic address: Marco.Donia@regionh.dk","institution_ids":["https://openalex.org/I124055696","https://openalex.org/I2801827564"]},{"raw_affiliation_string":"Center for Cancer Immune Therapy, Department of Haematology and Oncology, Herlev Hospital, University of Copenhagen, Herlev Ringvej 75, 2730 Herlev, Denmark","institution_ids":["https://openalex.org/I124055696","https://openalex.org/I2801827564"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051043977","display_name":"Inge Marie Svane","orcid":"https://orcid.org/0000-0002-9451-6037","observed_orcids":["https://orcid.org/0000-0002-9451-6037"]},"institutions":[{"id":"https://openalex.org/I124055696","display_name":"University of Copenhagen","ror":"https://ror.org/035b05819","country_code":"DK","type":"education","lineage":["https://openalex.org/I124055696"]},{"id":"https://openalex.org/I2801827564","display_name":"Herlev Hospital","ror":"https://ror.org/00wys9y90","country_code":"DK","type":"healthcare","lineage":["https://openalex.org/I2801827564","https://openalex.org/I2802567020"]}],"countries":["DK"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"I.M. Svane","raw_affiliation_strings":["Center for Cancer Immune Therapy, Department of Haematology and Oncology, Herlev Hospital, University of Copenhagen, Herlev Ringvej 75, 2730 Herlev, Denmark. Electronic address: Inge.Marie.Svane@regionh.dk","Center for Cancer Immune Therapy, Department of Haematology and Oncology, Herlev Hospital, University of Copenhagen, Herlev Ringvej 75, 2730 Herlev, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Cancer Immune Therapy, Department of Haematology and Oncology, Herlev Hospital, University of Copenhagen, Herlev Ringvej 75, 2730 Herlev, Denmark. Electronic address: Inge.Marie.Svane@regionh.dk","institution_ids":["https://openalex.org/I124055696","https://openalex.org/I2801827564"]},{"raw_affiliation_string":"Center for Cancer Immune Therapy, Department of Haematology and Oncology, Herlev Hospital, University of Copenhagen, Herlev Ringvej 75, 2730 Herlev, Denmark","institution_ids":["https://openalex.org/I124055696","https://openalex.org/I2801827564"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5017136846","display_name":"John B.A.G. Haanen","orcid":"https://orcid.org/0000-0001-5884-7704","observed_orcids":["https://orcid.org/0000-0001-5884-7704"]},"institutions":[{"id":"https://openalex.org/I2898336195","display_name":"The Netherlands Cancer Institute","ror":"https://ror.org/03xqtf034","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2898336195"]}],"countries":["NL"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"J.B.A.G. Haanen","raw_affiliation_strings":["Department of Medical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. Electronic address: j.haanen@nki.nl","Department of Medical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. Electronic address: j.haanen@nki.nl","institution_ids":["https://openalex.org/I2898336195"]},{"raw_affiliation_string":"Department of Medical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands","institution_ids":["https://openalex.org/I2898336195"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5017136846"],"corresponding_institution_ids":["https://openalex.org/I2898336195"],"apc_list":{"value":4300,"currency":"USD","value_usd":4300},"apc_paid":null,"fwci":1.2904,"has_fulltext":true,"cited_by_count":146,"citation_normalized_percentile":{"value":0.81061321,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":100},"biblio":{"volume":"9","issue":"10","first_page":"1918","last_page":"1935"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.5404999852180481,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.5404999852180481,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.24940000474452972,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.16200000047683716,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tumor-infiltrating-lymphocytes","display_name":"tumor-infiltrating lymphocytes","score":0.9980000257492065},{"id":"https://openalex.org/keywords/adoptive-immunotherapy","display_name":"adoptive immunotherapy","score":0.8569999933242798},{"id":"https://openalex.org/keywords/metastatic-melanoma","display_name":"metastatic melanoma","score":0.9980000257492065},{"id":"https://openalex.org/keywords/cancer-immunotherapy","display_name":"cancer immunotherapy","score":0.8299999833106995},{"id":"https://openalex.org/keywords/ctla-4-blockade","display_name":"CTLA-4 blockade","score":0.800000011920929},{"id":"https://openalex.org/keywords/anti-pd-1-therapy","display_name":"anti-PD-1 therapy","score":0.9909999966621399},{"id":"https://openalex.org/keywords/interleukin-2","display_name":"interleukin-2","score":0.6000000238418579},{"id":"https://openalex.org/keywords/mechanism-of-action","display_name":"mechanism of action","score":0.5910000205039978}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.856897234916687},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.8032290935516357},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.6856105327606201},{"id":"https://openalex.org/C2994587330","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Metastatic melanoma","level":3,"score":0.6719500422477722},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.561220645904541},{"id":"https://openalex.org/C2778326572","wikidata":"https://www.wikidata.org/wiki/Q7852668","display_name":"Tumor-infiltrating lymphocytes","level":4,"score":0.5265740752220154},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5072312355041504},{"id":"https://openalex.org/C2781433595","wikidata":"https://www.wikidata.org/wiki/Q2459042","display_name":"Ipilimumab","level":4,"score":0.4562474489212036},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.43287771940231323},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.42570945620536804},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.35732024908065796},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.34554576873779297}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000951","descriptor_name":"Antigens, Neoplasm","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008212","descriptor_name":"Lymphocyte Depletion","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009362","descriptor_name":"Neoplasm Metastasis","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D016246","descriptor_name":"Lymphocytes, Tumor-Infiltrating","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1016/j.molonc.2015.10.018","doi":"https://doi.org/10.1016/j.molonc.2015.10.018","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.molonc.2015.10.018","pdf_url":"https://febs.onlinelibrary.wiley.com/doi/pdfdirect/10.1016/j.molonc.2015.10.018","source":{"id":"https://openalex.org/S80282989","display_name":"Molecular Oncology","issn_l":"1574-7891","issn":["1574-7891","1878-0261"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","oarl","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Oncology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:5528735","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC5528735/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Mol Oncol","raw_type":"Text"},{"id":"pmid:26578452","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/26578452","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular oncology","raw_type":"Journal Article"},{"id":"pmh:oai:pure.atira.dk:openaire_cris_publications/01de42a7-f47b-45bc-af33-3cef30413df8","doi":null,"is_oa":false,"landing_page_url":"https://curis.ku.dk/portal/da/publications/tumorinfiltrating-lymphocytes-for-the-treatment-of-metastatic-cancer(01de42a7-f47b-45bc-af33-3cef30413df8).html","pdf_url":null,"source":{"id":"https://openalex.org/S4306401983","display_name":"Research at the University of Copenhagen (University of Copenhagen)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I124055696","host_organization_name":"University of Copenhagen","host_organization_lineage":["https://openalex.org/I124055696"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Geukes Foppen, M H, Donia, M, Svane, I M & Haanen, J B A G 2015, 'Tumor-infiltrating lymphocytes for the treatment of metastatic cancer', Molecular Oncology, vol. 9, no. 10, pp. 1918-35. https://doi.org/10.1016/j.molonc.2015.10.018","raw_type":"info:eu-repo/semantics/review"}],"best_oa_location":{"id":"doi:10.1016/j.molonc.2015.10.018","doi":"https://doi.org/10.1016/j.molonc.2015.10.018","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.molonc.2015.10.018","pdf_url":"https://febs.onlinelibrary.wiley.com/doi/pdfdirect/10.1016/j.molonc.2015.10.018","source":{"id":"https://openalex.org/S80282989","display_name":"Molecular Oncology","issn_l":"1574-7891","issn":["1574-7891","1878-0261"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","oarl","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1883154993.pdf","grobid_xml":"https://content.openalex.org/works/W1883154993.grobid-xml"},"referenced_works_count":118,"referenced_works":["https://openalex.org/W31349806","https://openalex.org/W52103172","https://openalex.org/W238163318","https://openalex.org/W1480965312","https://openalex.org/W1504799072","https://openalex.org/W1510445104","https://openalex.org/W1551156084","https://openalex.org/W1602008817","https://openalex.org/W1736513025","https://openalex.org/W1821140461","https://openalex.org/W1890985457","https://openalex.org/W1914337318","https://openalex.org/W1950572133","https://openalex.org/W1951776719","https://openalex.org/W1957293994","https://openalex.org/W1965029629","https://openalex.org/W1965370740","https://openalex.org/W1970151745","https://openalex.org/W1980137951","https://openalex.org/W1982374707","https://openalex.org/W1985981664","https://openalex.org/W1986046751","https://openalex.org/W1987350137","https://openalex.org/W1995621823","https://openalex.org/W1997292641","https://openalex.org/W2008494452","https://openalex.org/W2011458181","https://openalex.org/W2012951244","https://openalex.org/W2021472146","https://openalex.org/W2024657134","https://openalex.org/W2027726380","https://openalex.org/W2028789734","https://openalex.org/W2030259772","https://openalex.org/W2034359690","https://openalex.org/W2034745242","https://openalex.org/W2036392773","https://openalex.org/W2046183929","https://openalex.org/W2046407551","https://openalex.org/W2047203592","https://openalex.org/W2049491375","https://openalex.org/W2050407789","https://openalex.org/W2052912081","https://openalex.org/W2054851015","https://openalex.org/W2055087053","https://openalex.org/W2056964537","https://openalex.org/W2057948328","https://openalex.org/W2058899594","https://openalex.org/W2061572018","https://openalex.org/W2064273388","https://openalex.org/W2071122879","https://openalex.org/W2077027349","https://openalex.org/W2078197336","https://openalex.org/W2085935150","https://openalex.org/W2087025867","https://openalex.org/W2089828715","https://openalex.org/W2091246599","https://openalex.org/W2096387850","https://openalex.org/W2097173066","https://openalex.org/W2097995306","https://openalex.org/W2099842815","https://openalex.org/W2103876938","https://openalex.org/W2106511557","https://openalex.org/W2110660168","https://openalex.org/W2111711939","https://openalex.org/W2112121482","https://openalex.org/W2114230014","https://openalex.org/W2115094537","https://openalex.org/W2115241901","https://openalex.org/W2115511126","https://openalex.org/W2117925437","https://openalex.org/W2121545342","https://openalex.org/W2122066147","https://openalex.org/W2122507780","https://openalex.org/W2122795727","https://openalex.org/W2123909678","https://openalex.org/W2124373740","https://openalex.org/W2124446900","https://openalex.org/W2127334221","https://openalex.org/W2127734125","https://openalex.org/W2128035403","https://openalex.org/W2128542677","https://openalex.org/W2128758225","https://openalex.org/W2131473264","https://openalex.org/W2132923173","https://openalex.org/W2133075384","https://openalex.org/W2137074525","https://openalex.org/W2137088550","https://openalex.org/W2139517175","https://openalex.org/W2141269240","https://openalex.org/W2142257845","https://openalex.org/W2142300779","https://openalex.org/W2143523567","https://openalex.org/W2144223273","https://openalex.org/W2148368831","https://openalex.org/W2148523692","https://openalex.org/W2149209349","https://openalex.org/W2150633526","https://openalex.org/W2151246207","https://openalex.org/W2152061559","https://openalex.org/W2152897456","https://openalex.org/W2153590293","https://openalex.org/W2153712501","https://openalex.org/W2154042746","https://openalex.org/W2155026493","https://openalex.org/W2155959680","https://openalex.org/W2156000007","https://openalex.org/W2161101420","https://openalex.org/W2162184613","https://openalex.org/W2163825610","https://openalex.org/W2166262263","https://openalex.org/W2170069893","https://openalex.org/W2170137783","https://openalex.org/W2170403104","https://openalex.org/W2257968979","https://openalex.org/W2325650814","https://openalex.org/W2415425008","https://openalex.org/W4313310586","https://openalex.org/W7073583815"],"related_works":["https://openalex.org/W1989976028","https://openalex.org/W4310960675","https://openalex.org/W2895610076","https://openalex.org/W2019247653","https://openalex.org/W4400678891","https://openalex.org/W2766802590","https://openalex.org/W2150550959","https://openalex.org/W4390663023","https://openalex.org/W7133303194","https://openalex.org/W2410546872"],"abstract_inverted_index":{"Over":[0],"the":[1,35,41,53,97,116,128],"past":[2],"few":[3],"years":[4],"melanoma":[5,16,25],"incidence":[6],"has":[7,58],"been":[8],"rising":[9],"steadily,":[10],"resulting":[11],"in":[12,15,30,69],"an":[13],"increase":[14],"related":[17],"mortality.":[18],"Until":[19],"recently,":[20],"therapeutic":[21],"options":[22],"for":[23,88,105],"metastatic":[24,72,91],"were":[26,34],"scarce.":[27],"Chemotherapy":[28],"and,":[29],"some":[31],"countries,":[32],"IL-2":[33],"only":[36],"registered":[37],"treatment":[38,45,103],"modalities.":[39],"In":[40],"last":[42],"five":[43],"years,":[44],"with":[46,71,90],"immunotherapy":[47],"(anti":[48],"CTLA-4,":[49],"anti":[50],"PD-1,":[51],"or":[52],"combination":[54],"of":[55,99,109,125,131],"these":[56],"antibodies)":[57],"shown":[59],"very":[60],"promising":[61],"results":[62],"and":[63,111,115],"was":[64],"able":[65],"to":[66,118,122],"improve":[67],"survival":[68],"patients":[70,89],"melanoma.":[73,92],"Adoptive":[74],"cell":[75],"therapy":[76,121],"using":[77],"tumor-infiltrating":[78],"lymphocytes":[79],"is":[80],"yet":[81],"another,":[82],"but":[83],"highly":[84],"promising,":[85],"immunotherapeutic":[86],"strategy":[87],"This":[93],"review":[94],"will":[95,135],"discuss":[96],"development":[98],"TIL":[100,132],"as":[101],"a":[102],"option":[104],"melanoma,":[106],"its":[107],"mode":[108],"action":[110],"simplification":[112],"over":[113],"time,":[114],"possibilities":[117],"expand":[119],"this":[120],"other":[123],"types":[124],"cancer.":[126],"Also,":[127],"future":[129],"directions":[130],"based":[133],"therapies":[134],"be":[136],"highlighted.":[137]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1883154993","counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":14},{"year":2024,"cited_by_count":12},{"year":2023,"cited_by_count":8},{"year":2022,"cited_by_count":14},{"year":2021,"cited_by_count":22},{"year":2020,"cited_by_count":26},{"year":2019,"cited_by_count":11},{"year":2018,"cited_by_count":19},{"year":2017,"cited_by_count":8},{"year":2016,"cited_by_count":7},{"year":2015,"cited_by_count":2}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
